{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:42:21Z","timestamp":1740109341218,"version":"3.37.3"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Die im September 2024 ver\u00f6ffentlichten Leitlinien der European Society of Cardiology (ESC) zur peripheren arteriellen Verschlusskrankheit (pAVK) und zu aortalen Erkrankungen bilden erstmals Empfehlungen f\u00fcr beide Krankheitsbilder in einem gemeinsamen Leitliniendokument ab. Die Zusammenf\u00fchrung von pAVK- und Aortenleitlinien folgt einem ganzheitlichen Ansatz, der die Gesamtheit des arteriellen Gef\u00e4\u00dfsystems unterstreicht. Dieses Ziel wird durch eine eigens eingebrachte Empfehlung unterstrichen, bei Patienten mit Gef\u00e4\u00dferkrankungen die Gesamtheit des Kreislaufsystems zu ber\u00fccksichtigen. Schwerpunkt im aktuellen ESC-Leitlinien-Dokument ist das multidisziplin\u00e4re patientenzentrierte Management von pAVK und Aortenerkrankungen, wobei die Pr\u00e4vention und die Nachsorge nach therapeutischen Interventionen hervorgehoben werden. Insbesondere werden bei der pAVK das Gehtraining und das Prozedere bei chronischen Wunden sowie bei Aortenerkrankungen die Risikostratifizierung und heredit\u00e4re Aortenerkrankungen behandelt.<\/jats:p>","DOI":"10.1007\/s00059-024-05286-7","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T13:09:57Z","timestamp":1732626597000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Was ist neu im Management der peripheren arteriellen Verschlusskrankheit und der aortalen Erkrankungen?","What is new in the management of peripheral arterial occlusive disease and diseases of the aorta?"],"prefix":"10.1007","volume":"50","author":[{"given":"Heike","family":"Schulze-Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Staudacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Schlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"issue":"36","key":"5286_CR1","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai\u00a0L et\u00a0al (2024) 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart\u00a0J 45(36):3538\u20133700","journal-title":"Eur Heart J"},{"issue":"41","key":"5286_CR2","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"R Erbel","year":"2014","unstructured":"Erbel\u00a0R et\u00a0al (2014) ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart\u00a0J 35(41):2873\u20132926 (2014)","journal-title":"Eur Heart J"},{"issue":"9","key":"5286_CR3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2017","unstructured":"Aboyans\u00a0V et\u00a0al (2017) ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart\u00a0J 39(9):763\u2013816 (2018)","journal-title":"Eur Heart J"},{"issue":"8","key":"5286_CR4","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song\u00a0P et\u00a0al (2019) Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 7(8):e1020\u2013e1030","journal-title":"Lancet Glob Health"},{"issue":"10","key":"5286_CR5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","volume":"132","author":"U Campia","year":"2019","unstructured":"Campia\u00a0U et\u00a0al (2019) Peripheral Artery Disease: Past, Present, and Future. Am J Med 132(10):1133\u20131141","journal-title":"Am J Med"},{"issue":"1","key":"5286_CR6","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/j.jvs.2021.04.073","volume":"75","author":"AF AbuRahma","year":"2022","unstructured":"AbuRahma\u00a0AF et\u00a0al (2022) Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J\u00a0Vasc Surg 75(1):4S\u201322S","journal-title":"J Vasc Surg"},{"key":"5286_CR7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijcard.2022.09.045","volume":"371","author":"KI Paraskevas","year":"2023","unstructured":"Paraskevas\u00a0KI et\u00a0al (2023) Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A\u00a0plea for a\u00a0randomized controlled trial. Int J Cardiol 371:406\u2013412","journal-title":"Int J Cardiol"},{"key":"5286_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2020.09.026","volume":"315","author":"A Herraiz-Adillo","year":"2020","unstructured":"Herraiz-Adillo\u00a0A et\u00a0al (2020) The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A\u00a0systematic review and meta-analysis. Atherosclerosis 315:81\u201392","journal-title":"Atherosclerosis"},{"issue":"2","key":"5286_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1358863X17745371","volume":"23","author":"NK Itoga","year":"2018","unstructured":"Itoga\u00a0NK et\u00a0al (2018) Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vasc Med 23(2):97\u2013106","journal-title":"Vasc Med"},{"issue":"4","key":"5286_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cjca.2012.06.014","volume":"29","author":"D Xu","year":"2013","unstructured":"Xu\u00a0D et\u00a0al (2013) Diagnostic value of ankle-brachial index in peripheral arterial disease: a\u00a0meta-analysis. Can J Cardiol 29(4):492\u2013498","journal-title":"Can J Cardiol"},{"issue":"1","key":"5286_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jdiacomp.2015.07.019","volume":"30","author":"PE Tehan","year":"2016","unstructured":"Tehan\u00a0PE, Bray\u00a0A, Chuter\u00a0VH (2016) Non-invasive vascular assessment in the foot with diabetes: sensitivity and specificity of the ankle brachial index, toe brachial index and continuous wave Doppler for detecting peripheral arterial disease. J\u00a0Diabetes Complications 30(1):155\u2013160","journal-title":"J Diabetes Complications"},{"issue":"6","key":"5286_CR12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/hr.2016.13","volume":"39","author":"T Hashimoto","year":"2016","unstructured":"Hashimoto\u00a0T et\u00a0al (2016) Combination of pulse volume recording (PVR) parameters and ankle-brachial index (ABI) improves diagnostic accuracy for peripheral arterial disease compared with ABI alone. Hypertens Res 39(6):430\u2013434","journal-title":"Hypertens Res"},{"issue":"4","key":"5286_CR13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1358863X16645854","volume":"21","author":"PE Tehan","year":"2016","unstructured":"Tehan\u00a0PE, Santos\u00a0D, Chuter\u00a0VH (2016) A\u00a0systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease. Vasc Med 21(4):382\u2013389","journal-title":"Vasc Med"},{"key":"5286_CR14","doi-asserted-by":"crossref","unstructured":"Rodway AD et\u00a0al (2022) Ankle Doppler for Cuffless Ankle Brachial Index Estimation and Peripheral Artery Disease Diagnosis Independent of Diabetes. J\u00a0Clin Med 12(1)","DOI":"10.3390\/jcm12010097"},{"issue":"6","key":"5286_CR15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jvs.2014.08.107","volume":"60","author":"DL Cull","year":"2014","unstructured":"Cull\u00a0DL et\u00a0al (2014) An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J\u00a0Vasc Surg 60(6):1535\u20131541","journal-title":"J Vasc Surg"},{"issue":"4","key":"5286_CR16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.jfas.2023.02.003","volume":"62","author":"MD Liette","year":"2023","unstructured":"Liette\u00a0MD et\u00a0al (2023) A\u00a0Prospective Analysis of the SVS WIfI Classification System to Stratify Immediate and 1\u2011Year Patient Outcomes. J\u00a0Foot Ankle Surg 62(4):661\u2013665","journal-title":"J Foot Ankle Surg"},{"issue":"2","key":"5286_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1358863X211034577","volume":"27","author":"M Fassora","year":"2022","unstructured":"Fassora\u00a0M et\u00a0al (2022) Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: A\u00a0systematic review and meta-analysis. Vasc Med 27(2):158\u2013170","journal-title":"Vasc Med"},{"issue":"4","key":"5286_CR18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/eurjpc\/zwad261","volume":"31","author":"S Penin-Grandes","year":"2024","unstructured":"Penin-Grandes\u00a0S et\u00a0al (2024) Winners do what they fear: exercise and peripheral arterial disease\u2014an umbrella review. Eur J Prev Cardiol 31(4):380\u2013388","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"5286_CR19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jvs.2012.04.046","volume":"56","author":"F Fakhry","year":"2012","unstructured":"Fakhry\u00a0F et\u00a0al (2012) Supervised walking therapy in patients with intermittent claudication. J\u00a0Vasc Surg 56(4):1132\u20131142","journal-title":"J Vasc Surg"},{"issue":"2","key":"5286_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40279-014-0261-z","volume":"45","author":"BJ Parmenter","year":"2015","unstructured":"Parmenter\u00a0BJ, Dieberg\u00a0G, Smart\u00a0NA (2015) Exercise training for management of peripheral arterial disease: a\u00a0systematic review and meta-analysis. Sports Med 45(2):231\u2013244","journal-title":"Sports Med"},{"issue":"12","key":"5286_CR21","first-page":"CD000990","volume":"12","author":"R Lane","year":"2017","unstructured":"Lane\u00a0R et\u00a0al (2017) Exercise for intermittent claudication. Cochrane Database Syst Rev 12(12):CD990","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"5286_CR22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00007256-200434140-00004","volume":"34","author":"AC Bulmer","year":"2004","unstructured":"Bulmer\u00a0AC, Coombes\u00a0JS (2004) Optimising exercise training in peripheral arterial disease. Sports Med 34(14):983\u20131003","journal-title":"Sports Med"},{"issue":"5","key":"5286_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1024\/0301-1526\/a001024","volume":"51","author":"S Lanzi","year":"2022","unstructured":"Lanzi\u00a0S et\u00a0al (2022) Supervised exercise training in patients with lower extremity peripheral artery disease. Vasa 51(5):267\u2013274","journal-title":"Vasa"},{"issue":"4","key":"5286_CR24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/1526602820928590","volume":"27","author":"JA Mustapha","year":"2020","unstructured":"Mustapha\u00a0JA et\u00a0al (2020) Digital Subtraction Angiography Prior to an Amputation for Critical Limb Ischemia (CLI): An Expert Recommendation Statement From the CLI Global Society to Optimize Limb Salvage. J\u00a0Endovasc Ther 27(4):540\u2013546","journal-title":"J Endovasc Ther"},{"issue":"21","key":"5286_CR25","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca\u00a0MP et\u00a0al (2020) Rivaroxaban in Peripheral Artery Disease after Revascularization. N\u00a0Engl J Med 382(21):1994\u20132004","journal-title":"N Engl J Med"},{"issue":"10117","key":"5286_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","volume":"391","author":"SS Anand","year":"2018","unstructured":"Anand\u00a0SS et\u00a0al (2018) Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 391(10117):219\u2013229","journal-title":"Lancet"},{"issue":"1","key":"5286_CR27","first-page":"21","volume":"6","author":"E Kaplovitch","year":"2021","unstructured":"Kaplovitch\u00a0E et\u00a0al (2021) Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A\u00a0Subanalysis of the COMPASS Randomized Clinical Trial. JAMA Cardiol 6(1):21\u201329","journal-title":"JAMA Cardiol"},{"issue":"12","key":"5286_CR28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40265-022-01756-6","volume":"82","author":"LH Willems","year":"2022","unstructured":"Willems\u00a0LH et\u00a0al (2022) Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A\u00a0Systematic Review and Network Meta-Analysis. Drugs 82(12):1287\u20131302","journal-title":"Drugs"},{"issue":"20","key":"5286_CR29","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","volume":"71","author":"SS Anand","year":"2018","unstructured":"Anand\u00a0SS et\u00a0al (2018) Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. J\u00a0Am Coll Cardiol 71(20):2306\u20132315","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"5286_CR30","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1093\/eurheartj\/ehad269","volume":"44","author":"A Mente","year":"2023","unstructured":"Mente\u00a0A et\u00a0al (2023) Diet, cardiovascular disease, and mortality in 80\u00a0countries. Eur Heart\u00a0J 44(28):2560\u20132579","journal-title":"Eur Heart J"},{"issue":"8","key":"5286_CR31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/eurjpc\/zwad062","volume":"30","author":"D Wan","year":"2023","unstructured":"Wan\u00a0D et\u00a0al (2023) Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort. Eur J Prev Cardiol 30(8):709\u2013718","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"5286_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2021.11.005","volume":"41","author":"A Adegbola","year":"2022","unstructured":"Adegbola\u00a0A et\u00a0al (2022) The impact of nutrition on the development and progression of peripheral artery disease: A\u00a0systematic review. Clin Nutr 41(1):49\u201370","journal-title":"Clin Nutr"},{"key":"5286_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2018.05.049","volume":"275","author":"N Lopez-Laguna","year":"2018","unstructured":"Lopez-Laguna\u00a0N et\u00a0al (2018) Risk of peripheral artery disease according to a\u00a0healthy lifestyle score: The PREDIMED study. Atherosclerosis 275:133\u2013140","journal-title":"Atherosclerosis"},{"issue":"5","key":"5286_CR34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cjca.2022.01.021","volume":"38","author":"D Wan","year":"2022","unstructured":"Wan\u00a0D et\u00a0al (2022) Diet and Nutrition in Peripheral Artery Disease: A\u00a0Systematic Review. Can J Cardiol 38(5):672\u2013680","journal-title":"Can J Cardiol"},{"issue":"20","key":"5286_CR35","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1039\/D2FO02017C","volume":"13","author":"M Bapir","year":"2022","unstructured":"Bapir\u00a0M et\u00a0al (2022) Cocoa flavanol consumption improves lower extremity endothelial function in healthy individuals and people with type\u00a02 diabetes. Food Funct 13(20):10439\u201310448","journal-title":"Food Funct"},{"issue":"1","key":"5286_CR36","first-page":"CD010216","volume":"1","author":"N Lindson","year":"2024","unstructured":"Lindson\u00a0N et\u00a0al (2024) Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 1(1):CD10216","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5286_CR37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2018.4242","volume":"320","author":"JS Lin","year":"2018","unstructured":"Lin\u00a0JS et\u00a0al (2018) Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 320(3):281\u2013297","journal-title":"JAMA"},{"issue":"11","key":"5286_CR38","doi-asserted-by":"crossref","first-page":"e066950","DOI":"10.1136\/bmjopen-2022-066950","volume":"12","author":"P Normahani","year":"2022","unstructured":"Normahani\u00a0P et\u00a0al (2022) Study protocol for a\u00a0multicentre comparative diagnostic accuracy study of tools to establish the presence and severity of peripheral arterial disease in people with diabetes mellitus: the DM PAD study. Bmj Open 12(11):e66950","journal-title":"Bmj Open"},{"issue":"41","key":"5286_CR39","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","volume":"35","author":"DJ Kumbhani","year":"2014","unstructured":"Kumbhani\u00a0DJ et\u00a0al (2014) Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart\u00a0J 35(41):2864\u20132872","journal-title":"Eur Heart J"},{"issue":"5","key":"5286_CR40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709711","volume":"120","author":"D Pastori","year":"2020","unstructured":"Pastori\u00a0D et\u00a0al (2020) Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A\u00a0Systematic Review and Meta-Analysis. Thromb Haemost 120(5):866\u2013875","journal-title":"Thromb Haemost"},{"issue":"7","key":"5286_CR41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","volume":"63","author":"GG Westin","year":"2014","unstructured":"Westin\u00a0GG et\u00a0al (2014) Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J\u00a0Am Coll Cardiol 63(7):682\u2013690","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5286_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ehjcvp\/pvz081","volume":"7","author":"JF Dopheide","year":"2021","unstructured":"Dopheide\u00a0JF et\u00a0al (2021) Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. Eur Heart J Cardiovasc Pharmacother 7(4):263\u2013270","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"5286_CR43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach\u00a0F et\u00a0al (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart\u00a0J 41(1):111\u2013188","journal-title":"Eur Heart J"},{"issue":"9493","key":"5286_CR44","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent\u00a0C et\u00a0al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267\u20131278","journal-title":"Lancet"},{"issue":"38","key":"5286_CR45","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy\u00a0JW et\u00a0al (2024) 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart\u00a0J 45(38):3912\u20134018","journal-title":"Eur Heart J"},{"issue":"4","key":"5286_CR46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jacc.2015.10.077","volume":"67","author":"SA Murphy","year":"2016","unstructured":"Murphy\u00a0SA et\u00a0al (2016) Reduction in Total Cardiovascular Events With Ezetimibe\/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. J\u00a0Am Coll Cardiol 67(4):353\u2013361","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"5286_CR47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","volume":"6","author":"MP Bonaca","year":"2018","unstructured":"Bonaca\u00a0MP et\u00a0al (2018) Polyvascular disease, type\u00a02 diabetes, and long-term vascular risk: a\u00a0secondary analysis of the IMPROVE-IT trial. Lancet Diabetes Endocrinol 6(12):934\u2013943","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"5286_CR48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","volume":"137","author":"MP Bonaca","year":"2018","unstructured":"Bonaca\u00a0MP et\u00a0al (2018) Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation 137(4):338\u2013350","journal-title":"Circulation"},{"issue":"47","key":"5286_CR49","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1093\/eurheartj\/ehab604","volume":"42","author":"K Oyama","year":"2021","unstructured":"Oyama\u00a0K et\u00a0al (2021) Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial. Eur Heart\u00a0J 42(47):4821\u20134829","journal-title":"Eur Heart J"},{"issue":"15","key":"5286_CR50","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"SE Nissen","year":"2023","unstructured":"Nissen\u00a0SE et\u00a0al (2023) Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N\u00a0Engl J Med 388(15):1353\u20131364","journal-title":"N Engl J Med"},{"issue":"10305","key":"5286_CR51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","volume":"398","author":"Blood Pressure Lowering Treatment Trialists C.","year":"2021","unstructured":"Blood Pressure Lowering Treatment Trialists C. (2021) Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet 398(10305):1053\u20131064","journal-title":"Lancet"},{"issue":"10022","key":"5286_CR52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad\u00a0D et\u00a0al (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a\u00a0systematic review and meta-analysis. Lancet 387(10022):957\u2013967","journal-title":"Lancet"},{"issue":"24","key":"5286_CR53","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson\u00a0JD et\u00a0al (2016) Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged \u3009\/=75 Years: A\u00a0Randomized Clinical Trial. JAMA 315(24):2673\u20132682","journal-title":"JAMA"},{"issue":"14","key":"5286_CR54","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","volume":"385","author":"W Zhang","year":"2021","unstructured":"Zhang\u00a0W et\u00a0al (2021) Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N\u00a0Engl J Med 385(14):1268\u20131279","journal-title":"N Engl J Med"},{"issue":"12","key":"5286_CR55","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","volume":"32","author":"C Thomopoulos","year":"2014","unstructured":"Thomopoulos\u00a0C, Parati\u00a0G, Zanchetti\u00a0A (2014) Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J\u00a0Hypertens 32(12):2285\u20132295","journal-title":"J Hypertens"},{"issue":"7","key":"5286_CR56","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/dom.14700","volume":"24","author":"S Verma","year":"2022","unstructured":"Verma\u00a0S et\u00a0al (2022) Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease. Diabetes Obes Metab 24(7):1288\u20131299","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"5286_CR57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.117.032031","volume":"137","author":"S Verma","year":"2018","unstructured":"Verma\u00a0S et\u00a0al (2018) Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type\u00a02 Diabetes Mellitus and Peripheral Artery Disease: A\u00a0Subanalysis of EMPA-REG OUTCOME. Circulation 137(4):405\u2013407","journal-title":"Circulation"},{"issue":"7","key":"5286_CR58","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal\u00a0B et\u00a0al (2017) Canagliflozin and Cardiovascular and Renal Events in Type\u00a02 Diabetes. N\u00a0Engl J Med 377(7):644\u2013657","journal-title":"N Engl J Med"},{"issue":"2","key":"5286_CR59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","volume":"6","author":"DK McGuire","year":"2021","unstructured":"McGuire\u00a0DK et\u00a0al (2021) Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type\u00a02 Diabetes: A\u00a0Meta-analysis. JAMA Cardiol 6(2):148\u2013158","journal-title":"JAMA Cardiol"},{"issue":"2","key":"5286_CR60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","volume":"384","author":"DL Bhatt","year":"2021","unstructured":"Bhatt\u00a0DL et\u00a0al (2021) Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. N\u00a0Engl J Med 384(2):129\u2013139","journal-title":"N Engl J Med"},{"issue":"2","key":"5286_CR61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","volume":"384","author":"DL Bhatt","year":"2021","unstructured":"Bhatt\u00a0DL et\u00a0al (2021) Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. N\u00a0Engl J Med 384(2):117\u2013128","journal-title":"N Engl J Med"},{"issue":"4","key":"5286_CR62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott\u00a0SD et\u00a0al (2019) Dapagliflozin and Cardiovascular Outcomes in Type\u00a02 Diabetes. N\u00a0Engl J Med 380(4):347\u2013357","journal-title":"N Engl J Med"},{"issue":"22","key":"5286_CR63","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman\u00a0B et\u00a0al (2015) Empagliflozin, Cardiovascular Outcomes, and Mortality in Type\u00a02 Diabetes. N\u00a0Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"10","key":"5286_CR64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar\u00a0N et\u00a0al (2021) Cardiovascular, mortality, and kidney outcomes with GLP\u20111 receptor agonists in patients with type\u00a02 diabetes: a\u00a0systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol 9(10):653\u2013662","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10193","key":"5286_CR65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein\u00a0HC et\u00a0al (2019) Dulaglutide and cardiovascular outcomes in type\u00a02 diabetes (REWIND): a\u00a0double-blind, randomised placebo-controlled trial. Lancet 394(10193):121\u2013130","journal-title":"Lancet"},{"issue":"10","key":"5286_CR66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","volume":"385","author":"HC Gerstein","year":"2021","unstructured":"Gerstein\u00a0HC et\u00a0al (2021) Cardiovascular and Renal Outcomes with Efpeglenatide in Type\u00a02 Diabetes. N\u00a0Engl J Med 385(10):896\u2013907","journal-title":"N Engl J Med"},{"issue":"19","key":"5286_CR67","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso\u00a0SP et\u00a0al (2016) Semaglutide and Cardiovascular Outcomes in Patients with Type\u00a02 Diabetes. N\u00a0Engl J Med 375(19):1834\u20131844","journal-title":"N Engl J Med"},{"issue":"4","key":"5286_CR68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso\u00a0SP et\u00a0al (2016) Liraglutide and Cardiovascular Outcomes in Type\u00a02 Diabetes. N\u00a0Engl J Med 375(4):311\u2013322","journal-title":"N Engl J Med"},{"issue":"5","key":"5286_CR69","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1358863X211011253","volume":"26","author":"HL Gornik","year":"2021","unstructured":"Gornik\u00a0HL et\u00a0al (2021) Optimization of duplex velocity criteria for diagnosis of internal carotid artery (ICA) stenosis: A\u00a0report of the Intersocietal Accreditation Commission (IAC) Vascular Testing Division Carotid Diagnostic Criteria Committee. Vasc Med 26(5):515\u2013525","journal-title":"Vasc Med"},{"issue":"4","key":"5286_CR70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00013644-200312000-00005","volume":"19","author":"EG Grant","year":"2003","unstructured":"Grant\u00a0EG et\u00a0al (2003) Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis\u2014Society of Radiologists in Ultrasound consensus conference. Ultrasound\u00a0Q 19(4):190\u2013198","journal-title":"Ultrasound Q"},{"issue":"7","key":"5286_CR71","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","volume":"325","author":"North American Symptomatic Carotid Endarterectomy Trial C","year":"1991","unstructured":"North American Symptomatic Carotid Endarterectomy Trial C et\u00a0al (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N\u00a0Engl J Med 325(7):445\u2013453","journal-title":"N Engl J Med"},{"issue":"9113","key":"5286_CR72","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(97)09292-1","volume":"351","author":"-","year":"1998","unstructured":"- (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351(9113):1379\u20131387","journal-title":"Lancet"},{"issue":"6","key":"5286_CR73","first-page":"A4859","volume":"61","author":"L Klitfod","year":"2014","unstructured":"Klitfod\u00a0L, Jensen\u00a0LP (2014) Treatment of chronic upper limb ischaemia is safe and results are good. Dan Med\u00a0J 61(6):A4859","journal-title":"Dan Med J"},{"issue":"1","key":"5286_CR74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","volume":"370","author":"CJ Cooper","year":"2014","unstructured":"Cooper\u00a0CJ et\u00a0al (2014) Stenting and medical therapy for atherosclerotic renal-artery stenosis. N\u00a0Engl J Med 370(1):13\u201322","journal-title":"N Engl J Med"},{"issue":"12","key":"5286_CR75","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-150-12-200906160-00119","volume":"150","author":"L Bax","year":"2009","unstructured":"Bax\u00a0L et\u00a0al (2009) Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a\u00a0randomized trial. Ann Intern Med 150(12):840\u2013848 (W150-1)","journal-title":"Ann Intern Med"},{"issue":"20","key":"5286_CR76","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","volume":"361","author":"A Investigators","year":"2009","unstructured":"Investigators\u00a0A et\u00a0al (2009) Revascularization versus medical therapy for renal-artery stenosis. N\u00a0Engl J Med 361(20):1953\u20131962","journal-title":"N Engl J Med"},{"key":"5286_CR77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jhh.1000599","volume":"12(5","author":"J Webster","year":"1998","unstructured":"Webster\u00a0J et\u00a0al (1998) Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J\u00a0Hum Hypertens 12(5:329\u2013335","journal-title":"J Hum Hypertens"},{"issue":"14","key":"5286_CR78","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM200004063421403","volume":"342","author":"BC van Jaarsveld","year":"2000","unstructured":"van Jaarsveld\u00a0BC et\u00a0al (2000) The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N\u00a0Engl J Med 342(14):1007\u20131014","journal-title":"N Engl J Med"},{"issue":"3","key":"5286_CR79","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.HYP.31.3.823","volume":"31","author":"PF Plouin","year":"1998","unstructured":"Plouin\u00a0PF et\u00a0al (1998) Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a\u00a0randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 31(3):823\u2013829","journal-title":"Hypertension"},{"issue":"9141","key":"5286_CR80","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(98)10137-X","volume":"352","author":"-","year":"1998","unstructured":"- (1998) Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 352(9141):1649\u20131655","journal-title":"Lancet"},{"issue":"19","key":"5286_CR81","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa013527","volume":"346","author":"United Kingdom Small Aneurysm Trial P","year":"2002","unstructured":"United Kingdom Small Aneurysm Trial P et\u00a0al (2002) Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N\u00a0Engl J Med 346(19):1445\u20131452","journal-title":"N Engl J Med"},{"issue":"19","key":"5286_CR82","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMoa012573","volume":"346","author":"FA Lederle","year":"2002","unstructured":"Lederle\u00a0FA et\u00a0al (2002) Immediate repair compared with surveillance of small abdominal aortic aneurysms. N\u00a0Engl J Med 346(19):1437\u20131444","journal-title":"N Engl J Med"},{"issue":"3","key":"5286_CR83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1358863X211061603","volume":"27","author":"T Shirasu","year":"2022","unstructured":"Shirasu\u00a0T et\u00a0al (2022) Smaller size is more suitable for pharmacotherapy among undersized abdominal aortic aneurysm: A\u00a0systematic review and meta-analysis. Vasc Med 27(3):261\u2013268","journal-title":"Vasc Med"},{"key":"5286_CR84","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/SLA.0000000000003529","volume":"270(5","author":"EG Karthaus","year":"2019","unstructured":"Karthaus\u00a0EG et\u00a0al (2019) Saccular Abdominal Aortic Aneurysms: Patient Characteristics, Clinical Presentation, Treatment, and Outcomes in the Netherlands. Ann Surg 270(5:852\u2013858","journal-title":"Ann Surg"},{"issue":"9","key":"5286_CR85","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.echo.2016.04.006","volume":"29","author":"JF Rodriguez-Palomares","year":"2016","unstructured":"Rodriguez-Palomares\u00a0JF et\u00a0al (2016) Multimodality Assessment of Ascending Aortic Diameters: Comparison of Different Measurement Methods. J\u00a0Am Soc Echocardiogr 29(9):819\u2013826","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"5286_CR86","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.hlc.2015.05.001","volume":"24","author":"BT Fitzgerald","year":"2015","unstructured":"Fitzgerald\u00a0BT, Kwon\u00a0A, Scalia\u00a0GM (2015) The New Dimension in Aortic Measurements\u2014Use of the Inner Edge Measurement for the Thoracic Aorta in Australian Patients. Heart Lung Circ 24(11):1104\u20131110","journal-title":"Heart Lung Circ"},{"issue":"2","key":"5286_CR87","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCIMAGING.108.768911","volume":"1","author":"ED Burman","year":"2008","unstructured":"Burman\u00a0ED, Keegan\u00a0J, Kilner\u00a0PJ (2008) Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging 1(2):104\u2013113","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"5286_CR88","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2016.06.025","volume":"68","author":"JB Kim","year":"2016","unstructured":"Kim\u00a0JB et\u00a0al (2016) Risk of Aortic Dissection in the Moderately Dilated Ascending Aorta. J\u00a0Am Coll Cardiol 68(11):1209\u20131219","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5286_CR89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0022-5223(97)70360-X","volume":"113","author":"MA Coady","year":"1997","unstructured":"Coady\u00a0MA et\u00a0al (1997) What is the appropriate size criterion for resection of thoracic aortic aneurysms? J\u00a0Thorac Cardiovasc Surg 113(3):476\u2013491 (discussion 489\u201391)","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"5286_CR90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0003-4975(01)03236-2","volume":"73","author":"RR Davies","year":"2002","unstructured":"Davies\u00a0RR et\u00a0al (2002) Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 73(1):17\u201327 (discussion 27\u20138)","journal-title":"Ann Thorac Surg"},{"issue":"24","key":"5286_CR91","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1161\/CIR.0000000000001106","volume":"146","author":"EM Isselbacher","year":"2022","unstructured":"Isselbacher\u00a0EM et\u00a0al (2022) 2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic Disease: A\u00a0Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 146(24):e334\u2013e482","journal-title":"Circulation"},{"issue":"2","key":"5286_CR92","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jtcvs.2019.10.125","volume":"161","author":"MA Zafar","year":"2021","unstructured":"Zafar\u00a0MA et\u00a0al (2021) Natural history of descending thoracic and thoracoabdominal aortic aneurysms. J\u00a0Thorac Cardiovasc Surg 161(2):498\u2013511","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"17","key":"5286_CR93","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/CIRCULATIONAHA.114.015177","volume":"132","author":"JB Kim","year":"2015","unstructured":"Kim\u00a0JB et\u00a0al (2015) Risk of rupture or dissection in descending thoracic aortic aneurysm. Circulation 132(17):1620\u20131629","journal-title":"Circulation"},{"issue":"4","key":"5286_CR94","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0733-8651(05)70105-3","volume":"17","author":"MA Coady","year":"1999","unstructured":"Coady\u00a0MA et\u00a0al (1999) Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 17(4):615\u2013635","journal-title":"Cardiol Clin"},{"issue":"22","key":"5286_CR95","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro\u00a0RV et\u00a0al (2014) Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome. N\u00a0Engl J Med 371(22):2061\u20132071","journal-title":"N Engl J Med"},{"issue":"14","key":"5286_CR96","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jacc.2018.07.052","volume":"72","author":"G Teixido-Tura","year":"2018","unstructured":"Teixido-Tura\u00a0G et\u00a0al (2018) Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. J\u00a0Am Coll Cardiol 72(14):1613\u20131618","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05286-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-024-05286-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05286-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:51:32Z","timestamp":1738003892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-024-05286-7"}},"subtitle":["Highlights der ESC-Leitlinien 2024","Highlights of the ESC guidelines 2024"],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["5286"],"URL":"https:\/\/doi.org\/10.1007\/s00059-024-05286-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"22 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Schulze-Bauer, M.\u00a0Staudacher, S.\u00a0Steiner und O.\u00a0Schlager geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}